CNSP financials

CNS Pharmaceuticals (CNSP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CNSP income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$15.99M-$15.85M-1072.50
2024––-$14.90M-$14.86M-14006.70
2023––-$18.87M-$18.85M-4507575.36
2022––-$15.27M-$15.27M-10107558.22
2021––-$14.49M-$14.50M-14864056.21
2020––-$9.45M-$9.46M-513485.58